Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 84 | 2024 | 4270 | 7.460 |
Why?
|
Graft Rejection | 73 | 2024 | 4499 | 4.820 |
Why?
|
BK Virus | 8 | 2024 | 121 | 3.020 |
Why?
|
Graft Survival | 40 | 2024 | 3890 | 2.710 |
Why?
|
Polyomavirus Infections | 7 | 2024 | 194 | 2.220 |
Why?
|
Immunosuppressive Agents | 35 | 2022 | 4209 | 1.820 |
Why?
|
Heart Transplantation | 35 | 2020 | 3310 | 1.670 |
Why?
|
Organ Transplantation | 12 | 2024 | 1174 | 1.640 |
Why?
|
Viremia | 6 | 2024 | 727 | 1.550 |
Why?
|
T-Lymphocytes, Regulatory | 12 | 2022 | 3111 | 1.440 |
Why?
|
Transplantation | 4 | 2019 | 222 | 1.420 |
Why?
|
Facial Transplantation | 7 | 2021 | 221 | 1.360 |
Why?
|
Kidney Failure, Chronic | 13 | 2024 | 2495 | 1.330 |
Why?
|
HLA Antigens | 11 | 2021 | 1339 | 1.280 |
Why?
|
Tumor Virus Infections | 5 | 2024 | 440 | 1.230 |
Why?
|
Immunoconjugates | 29 | 2013 | 981 | 1.150 |
Why?
|
Isoantibodies | 9 | 2024 | 681 | 1.120 |
Why?
|
Immune Tolerance | 17 | 2020 | 2324 | 0.900 |
Why?
|
Histocompatibility Testing | 7 | 2021 | 726 | 0.780 |
Why?
|
Plasmapheresis | 4 | 2024 | 205 | 0.780 |
Why?
|
Apolipoproteins | 2 | 2016 | 327 | 0.760 |
Why?
|
Antigens, Differentiation | 26 | 2007 | 919 | 0.750 |
Why?
|
Lipoproteins, HDL | 3 | 2016 | 674 | 0.750 |
Why?
|
Magnesium Deficiency | 1 | 2020 | 47 | 0.700 |
Why?
|
Dendritic Cells | 5 | 2019 | 2747 | 0.690 |
Why?
|
Reperfusion Injury | 5 | 2020 | 1042 | 0.690 |
Why?
|
Histocompatibility | 3 | 2018 | 327 | 0.690 |
Why?
|
Antiviral Agents | 7 | 2018 | 3050 | 0.670 |
Why?
|
T-Lymphocytes | 32 | 2024 | 10261 | 0.650 |
Why?
|
Kidney | 15 | 2024 | 7066 | 0.650 |
Why?
|
Transplantation, Homologous | 24 | 2023 | 4860 | 0.630 |
Why?
|
Tissue Donors | 13 | 2021 | 2395 | 0.620 |
Why?
|
HMGB1 Protein | 2 | 2020 | 139 | 0.620 |
Why?
|
Magnesium | 2 | 2022 | 813 | 0.590 |
Why?
|
Th2 Cells | 9 | 2018 | 1075 | 0.570 |
Why?
|
Transplants | 1 | 2019 | 208 | 0.550 |
Why?
|
Rats, Inbred Lew | 29 | 2010 | 1167 | 0.550 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2022 | 669 | 0.530 |
Why?
|
Hemodiafiltration | 1 | 2016 | 19 | 0.530 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1857 | 0.510 |
Why?
|
Living Donors | 4 | 2018 | 645 | 0.500 |
Why?
|
Anti-Infective Agents | 2 | 2014 | 986 | 0.490 |
Why?
|
Crime | 1 | 2016 | 206 | 0.480 |
Why?
|
Immune System | 2 | 2019 | 799 | 0.450 |
Why?
|
Hypoparathyroidism | 1 | 2015 | 136 | 0.450 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1510 | 0.440 |
Why?
|
Renal Replacement Therapy | 1 | 2016 | 281 | 0.440 |
Why?
|
Teriparatide | 1 | 2015 | 225 | 0.430 |
Why?
|
Interleukin-6 | 5 | 2017 | 3222 | 0.430 |
Why?
|
Parathyroidectomy | 1 | 2015 | 244 | 0.430 |
Why?
|
Tissue and Organ Harvesting | 1 | 2016 | 373 | 0.420 |
Why?
|
Postoperative Complications | 11 | 2024 | 15747 | 0.410 |
Why?
|
Atovaquone | 1 | 2012 | 56 | 0.400 |
Why?
|
Antigens, CD | 31 | 2011 | 4025 | 0.390 |
Why?
|
Humans | 129 | 2024 | 765968 | 0.380 |
Why?
|
Tissue and Organ Procurement | 2 | 2019 | 989 | 0.380 |
Why?
|
Lectins, C-Type | 1 | 2015 | 592 | 0.380 |
Why?
|
Pneumocystis carinii | 1 | 2012 | 70 | 0.370 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2014 | 1347 | 0.370 |
Why?
|
Lymphocyte Activation | 15 | 2021 | 5501 | 0.370 |
Why?
|
Complement System Proteins | 1 | 2014 | 715 | 0.370 |
Why?
|
Isoantigens | 8 | 2022 | 562 | 0.360 |
Why?
|
Diarrhea | 1 | 2017 | 1316 | 0.360 |
Why?
|
Fluoroquinolones | 2 | 2010 | 307 | 0.350 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2012 | 239 | 0.350 |
Why?
|
Virus Activation | 2 | 2017 | 323 | 0.350 |
Why?
|
Hypophosphatemia | 1 | 2011 | 92 | 0.340 |
Why?
|
Transplantation Tolerance | 5 | 2022 | 640 | 0.340 |
Why?
|
Thymus Gland | 5 | 2012 | 1261 | 0.340 |
Why?
|
Biopsy | 10 | 2019 | 6763 | 0.340 |
Why?
|
Kidney Diseases | 6 | 2020 | 2098 | 0.310 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 544 | 0.310 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1612 | 0.310 |
Why?
|
Biological Products | 1 | 2018 | 942 | 0.300 |
Why?
|
Anemia | 3 | 2008 | 1511 | 0.300 |
Why?
|
Bone Density Conservation Agents | 1 | 2015 | 791 | 0.300 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 234 | 0.300 |
Why?
|
Models, Immunological | 4 | 2018 | 517 | 0.280 |
Why?
|
Antibodies, Monoclonal | 15 | 2013 | 9249 | 0.280 |
Why?
|
Phosphates | 1 | 2011 | 763 | 0.280 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2011 | 1151 | 0.280 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2012 | 504 | 0.280 |
Why?
|
Middle Aged | 52 | 2024 | 223009 | 0.270 |
Why?
|
Animals | 78 | 2024 | 168764 | 0.270 |
Why?
|
Lung Transplantation | 4 | 2021 | 1311 | 0.270 |
Why?
|
Clone Cells | 4 | 2009 | 1672 | 0.270 |
Why?
|
Rats | 39 | 2021 | 23707 | 0.260 |
Why?
|
Edema | 1 | 2010 | 760 | 0.260 |
Why?
|
Male | 77 | 2024 | 363698 | 0.250 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6493 | 0.250 |
Why?
|
Th1 Cells | 6 | 2016 | 1039 | 0.250 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2817 | 0.250 |
Why?
|
Hypertension, Malignant | 1 | 2005 | 17 | 0.250 |
Why?
|
Female | 65 | 2024 | 396112 | 0.250 |
Why?
|
Autoantibodies | 3 | 2021 | 2113 | 0.240 |
Why?
|
Renal Insufficiency | 1 | 2011 | 804 | 0.240 |
Why?
|
Membrane Glycoproteins | 10 | 2011 | 3690 | 0.240 |
Why?
|
Rats, Inbred WF | 12 | 2003 | 139 | 0.240 |
Why?
|
Dyslipidemias | 1 | 2012 | 869 | 0.230 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2005 | 153 | 0.230 |
Why?
|
Immunologic Factors | 3 | 2019 | 1587 | 0.230 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2016 | 615 | 0.230 |
Why?
|
Ganciclovir | 1 | 2004 | 257 | 0.220 |
Why?
|
CD4-Positive T-Lymphocytes | 9 | 2017 | 4405 | 0.220 |
Why?
|
Membrane Proteins | 4 | 2021 | 7851 | 0.220 |
Why?
|
Adult | 42 | 2024 | 223044 | 0.220 |
Why?
|
Acute Disease | 11 | 2021 | 7232 | 0.220 |
Why?
|
Antigens, Surface | 1 | 2008 | 1617 | 0.210 |
Why?
|
Glomerulonephritis | 3 | 2014 | 332 | 0.210 |
Why?
|
Mycophenolic Acid | 2 | 2011 | 346 | 0.210 |
Why?
|
CD40 Ligand | 5 | 2002 | 528 | 0.210 |
Why?
|
Treatment Outcome | 21 | 2024 | 65188 | 0.210 |
Why?
|
Antilymphocyte Serum | 3 | 2011 | 493 | 0.200 |
Why?
|
Histocompatibility Antigens Class II | 7 | 2008 | 1441 | 0.200 |
Why?
|
Sepsis | 1 | 2016 | 2606 | 0.190 |
Why?
|
Genetic Variation | 1 | 2017 | 6610 | 0.190 |
Why?
|
Cyclosporine | 8 | 2011 | 778 | 0.190 |
Why?
|
Nephrosis, Lipoid | 1 | 2021 | 45 | 0.190 |
Why?
|
Time Factors | 20 | 2020 | 40065 | 0.190 |
Why?
|
Mice, Inbred BALB C | 7 | 2020 | 6220 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 888 | 0.180 |
Why?
|
Histocompatibility Antigens | 4 | 2013 | 477 | 0.180 |
Why?
|
RNA, Messenger | 3 | 2015 | 12768 | 0.180 |
Why?
|
Rats, Inbred F344 | 6 | 2010 | 822 | 0.170 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2023 | 333 | 0.170 |
Why?
|
Creatinine | 4 | 2017 | 1915 | 0.170 |
Why?
|
Antibodies | 5 | 2021 | 2417 | 0.170 |
Why?
|
Nephrotic Syndrome | 1 | 2023 | 380 | 0.170 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 433 | 0.170 |
Why?
|
Calcium Oxalate | 1 | 2020 | 75 | 0.170 |
Why?
|
Chronic Disease | 12 | 2017 | 9347 | 0.160 |
Why?
|
Hepatitis C, Chronic | 2 | 2018 | 1032 | 0.160 |
Why?
|
Glomerular Filtration Rate | 5 | 2024 | 2233 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2019 | 3513 | 0.160 |
Why?
|
Mortality | 1 | 2010 | 2904 | 0.160 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7478 | 0.160 |
Why?
|
Th17 Cells | 2 | 2018 | 786 | 0.160 |
Why?
|
Interferon-gamma | 6 | 2016 | 3160 | 0.160 |
Why?
|
Mice | 30 | 2021 | 81819 | 0.150 |
Why?
|
Preoperative Care | 2 | 2014 | 2267 | 0.150 |
Why?
|
Interleukin-1beta | 3 | 2014 | 1028 | 0.150 |
Why?
|
Retrospective Studies | 19 | 2024 | 81514 | 0.150 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2018 | 86 | 0.150 |
Why?
|
Vascular Diseases | 2 | 2019 | 1159 | 0.150 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2016 | 2056 | 0.150 |
Why?
|
Adenosine Triphosphate | 2 | 2022 | 1999 | 0.150 |
Why?
|
Cytomegalovirus Infections | 1 | 2004 | 836 | 0.150 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2024 | 669 | 0.150 |
Why?
|
Transplantation Immunology | 4 | 2008 | 541 | 0.140 |
Why?
|
Skin Transplantation | 9 | 2014 | 1098 | 0.140 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2018 | 84 | 0.140 |
Why?
|
Prospective Studies | 16 | 2024 | 54802 | 0.140 |
Why?
|
Aged | 25 | 2024 | 171117 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2024 | 12437 | 0.140 |
Why?
|
Prognosis | 8 | 2024 | 29922 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor C | 2 | 2019 | 124 | 0.140 |
Why?
|
Granzymes | 2 | 2017 | 278 | 0.140 |
Why?
|
Interleukin-17 | 2 | 2016 | 921 | 0.140 |
Why?
|
Monocytes | 3 | 2017 | 2595 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2310 | 0.130 |
Why?
|
Neoplasms | 2 | 2024 | 22340 | 0.130 |
Why?
|
Antibodies, Blocking | 3 | 2013 | 249 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3181 | 0.130 |
Why?
|
Transplantation Conditioning | 3 | 2018 | 1635 | 0.130 |
Why?
|
Mice, Inbred C57BL | 13 | 2020 | 22332 | 0.130 |
Why?
|
Microscopy, Electron | 3 | 2015 | 2548 | 0.130 |
Why?
|
Signal Transduction | 8 | 2024 | 23601 | 0.120 |
Why?
|
Antigen Presentation | 1 | 2021 | 1250 | 0.120 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6544 | 0.120 |
Why?
|
Inflammation Mediators | 1 | 2024 | 1884 | 0.120 |
Why?
|
Antigens, CD1 | 1 | 2018 | 435 | 0.120 |
Why?
|
Cryopreservation | 2 | 2017 | 728 | 0.120 |
Why?
|
Primary Graft Dysfunction | 1 | 2016 | 112 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2018 | 7425 | 0.120 |
Why?
|
House Calls | 1 | 2017 | 171 | 0.120 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4274 | 0.120 |
Why?
|
Organ Culture Techniques | 1 | 2017 | 788 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2017 | 4642 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 74840 | 0.120 |
Why?
|
Mice, Knockout | 7 | 2013 | 14448 | 0.120 |
Why?
|
Risk Assessment | 5 | 2019 | 24282 | 0.120 |
Why?
|
Receptors, Immunologic | 1 | 2021 | 1415 | 0.120 |
Why?
|
Toll-Like Receptor 8 | 1 | 2015 | 98 | 0.120 |
Why?
|
Receptors, Interleukin-2 | 2 | 2011 | 561 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1808 | 0.120 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.110 |
Why?
|
Kidney Function Tests | 3 | 2024 | 683 | 0.110 |
Why?
|
Gene Expression | 4 | 2021 | 7584 | 0.110 |
Why?
|
Waiting Lists | 1 | 2019 | 777 | 0.110 |
Why?
|
Nephritis | 1 | 2015 | 146 | 0.110 |
Why?
|
Fluorocarbons | 1 | 2019 | 497 | 0.110 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 390 | 0.110 |
Why?
|
Toll-Like Receptor 7 | 1 | 2015 | 169 | 0.110 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2017 | 545 | 0.110 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 100 | 0.110 |
Why?
|
Ultrasonography, Interventional | 2 | 2019 | 1531 | 0.110 |
Why?
|
Immunity, Cellular | 4 | 2014 | 1555 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3737 | 0.110 |
Why?
|
Receptors, Purinergic | 1 | 2014 | 66 | 0.110 |
Why?
|
Regenerative Medicine | 1 | 2017 | 303 | 0.110 |
Why?
|
Organ Preservation | 1 | 2017 | 399 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 583 | 0.100 |
Why?
|
Face | 1 | 2019 | 1028 | 0.100 |
Why?
|
DNA, Viral | 3 | 2017 | 2199 | 0.100 |
Why?
|
Exosomes | 1 | 2017 | 421 | 0.100 |
Why?
|
Health Facilities | 1 | 2018 | 577 | 0.100 |
Why?
|
Skin | 3 | 2021 | 4489 | 0.100 |
Why?
|
Viral Load | 2 | 2014 | 3386 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2018 | 1441 | 0.100 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 303 | 0.100 |
Why?
|
Glycolysis | 1 | 2016 | 838 | 0.100 |
Why?
|
Cytokines | 12 | 2021 | 7421 | 0.100 |
Why?
|
Janus Kinases | 1 | 2013 | 253 | 0.100 |
Why?
|
Autoimmunity | 2 | 2019 | 1354 | 0.100 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2007 | 511 | 0.100 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 379 | 0.100 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15398 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 4 | 2000 | 820 | 0.100 |
Why?
|
Inflammation | 3 | 2024 | 10850 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2570 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 811 | 0.100 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 568 | 0.090 |
Why?
|
Biosensing Techniques | 1 | 2017 | 642 | 0.090 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39193 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2018 | 2424 | 0.090 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 691 | 0.090 |
Why?
|
Calcium Compounds | 1 | 2011 | 40 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2453 | 0.090 |
Why?
|
Boston | 3 | 2014 | 9338 | 0.090 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2013 | 254 | 0.090 |
Why?
|
Cells, Cultured | 9 | 2017 | 18973 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 2 | 2020 | 1663 | 0.090 |
Why?
|
Self Tolerance | 1 | 2011 | 119 | 0.090 |
Why?
|
Endothelium, Vascular | 2 | 2014 | 4427 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2013 | 4348 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2878 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 11888 | 0.090 |
Why?
|
Macrophage Activation | 1 | 2013 | 552 | 0.090 |
Why?
|
Glycoproteins | 1 | 2018 | 2195 | 0.090 |
Why?
|
Ureteral Neoplasms | 1 | 2011 | 106 | 0.080 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18293 | 0.080 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 494 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2011 | 1801 | 0.080 |
Why?
|
Growth Inhibitors | 1 | 2011 | 376 | 0.080 |
Why?
|
Peptides | 3 | 2011 | 4331 | 0.080 |
Why?
|
Lipids | 1 | 2021 | 3315 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1745 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9525 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 2210 | 0.080 |
Why?
|
Acetates | 1 | 2011 | 313 | 0.080 |
Why?
|
Prevalence | 4 | 2008 | 15842 | 0.080 |
Why?
|
Imidazoles | 1 | 2015 | 1162 | 0.080 |
Why?
|
Nephrology | 2 | 2017 | 270 | 0.080 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.080 |
Why?
|
Cell Movement | 2 | 2018 | 5194 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3251 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2172 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4778 | 0.080 |
Why?
|
Tacrolimus | 3 | 2011 | 753 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2019 | 3081 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4044 | 0.070 |
Why?
|
Flow Cytometry | 4 | 2012 | 5881 | 0.070 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5444 | 0.070 |
Why?
|
Rats, Inbred BN | 8 | 1999 | 229 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2016 | 10429 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1946 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 608 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2017 | 997 | 0.070 |
Why?
|
Endomyocardial Fibrosis | 1 | 2007 | 41 | 0.070 |
Why?
|
Interleukin-23 | 1 | 2009 | 202 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1668 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3708 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2898 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 4 | 2016 | 2476 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1940 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2009 | 1884 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2334 | 0.070 |
Why?
|
Polysaccharides, Bacterial | 2 | 1999 | 576 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2692 | 0.070 |
Why?
|
Apoptosis | 5 | 2017 | 9514 | 0.070 |
Why?
|
Immunization | 3 | 2003 | 1219 | 0.070 |
Why?
|
Simian virus 40 | 1 | 2007 | 290 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6499 | 0.070 |
Why?
|
Down-Regulation | 2 | 2011 | 2927 | 0.060 |
Why?
|
Foot | 1 | 2010 | 573 | 0.060 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2007 | 255 | 0.060 |
Why?
|
Communicable Diseases | 1 | 2014 | 874 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1959 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1242 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2001 | 1365 | 0.060 |
Why?
|
Polyomavirus | 1 | 2006 | 236 | 0.060 |
Why?
|
Chimera | 2 | 2004 | 455 | 0.060 |
Why?
|
Obesity | 2 | 2017 | 13076 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2229 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2011 | 3446 | 0.060 |
Why?
|
Urine | 1 | 2006 | 360 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3390 | 0.060 |
Why?
|
Immunophenotyping | 3 | 2017 | 1866 | 0.060 |
Why?
|
Hand | 1 | 2010 | 909 | 0.060 |
Why?
|
Antigen-Presenting Cells | 3 | 2011 | 962 | 0.060 |
Why?
|
Lymphocytes | 5 | 2004 | 2599 | 0.060 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2011 | 790 | 0.060 |
Why?
|
Drug Antagonism | 1 | 2004 | 50 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5849 | 0.060 |
Why?
|
Phosphotyrosine | 1 | 2005 | 459 | 0.060 |
Why?
|
Hyperhomocysteinemia | 1 | 2004 | 117 | 0.060 |
Why?
|
Mesoderm | 1 | 2007 | 679 | 0.060 |
Why?
|
Models, Animal | 1 | 2010 | 2120 | 0.060 |
Why?
|
Disease Progression | 6 | 2017 | 13632 | 0.060 |
Why?
|
Mycoses | 1 | 2007 | 389 | 0.060 |
Why?
|
Linear Models | 1 | 2014 | 5876 | 0.050 |
Why?
|
Cell Line | 5 | 2011 | 15543 | 0.050 |
Why?
|
Heart Failure | 2 | 2019 | 11840 | 0.050 |
Why?
|
Heart | 1 | 2016 | 4414 | 0.050 |
Why?
|
Rats, Inbred Strains | 3 | 2000 | 2077 | 0.050 |
Why?
|
Sclerosis | 1 | 2023 | 211 | 0.050 |
Why?
|
Cohort Studies | 7 | 2021 | 41649 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8297 | 0.050 |
Why?
|
Nutrition Surveys | 1 | 2010 | 1741 | 0.050 |
Why?
|
Administration, Oral | 1 | 2011 | 4015 | 0.050 |
Why?
|
Aorta | 1 | 2010 | 2028 | 0.050 |
Why?
|
Chemokine CCL2 | 2 | 2012 | 602 | 0.050 |
Why?
|
United States | 7 | 2021 | 72903 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3529 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2021 | 790 | 0.050 |
Why?
|
Heart Diseases | 1 | 2015 | 2821 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.050 |
Why?
|
Immunohistochemistry | 5 | 2021 | 11022 | 0.050 |
Why?
|
Antifungal Agents | 1 | 2007 | 769 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12795 | 0.050 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2001 | 58 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11641 | 0.050 |
Why?
|
Incidence | 4 | 2015 | 21480 | 0.050 |
Why?
|
Ribonucleases | 1 | 2002 | 265 | 0.050 |
Why?
|
Homocysteine | 1 | 2004 | 638 | 0.050 |
Why?
|
DNA Helicases | 1 | 2007 | 852 | 0.050 |
Why?
|
Surgery, Plastic | 1 | 2008 | 651 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2880 | 0.050 |
Why?
|
Postoperative Period | 1 | 2006 | 1816 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12056 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 2002 | 752 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3646 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 894 | 0.040 |
Why?
|
Bone Marrow | 1 | 2011 | 2921 | 0.040 |
Why?
|
Interleukins | 2 | 2013 | 791 | 0.040 |
Why?
|
Cell Line, Tumor | 5 | 2016 | 17075 | 0.040 |
Why?
|
Adoptive Transfer | 4 | 2011 | 827 | 0.040 |
Why?
|
Bone Marrow Transplantation | 2 | 1999 | 2729 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 591 | 0.040 |
Why?
|
Bacterial Vaccines | 2 | 1999 | 400 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 59889 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5337 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2002 | 1061 | 0.040 |
Why?
|
Protein Binding | 3 | 2011 | 9296 | 0.040 |
Why?
|
Hepatocyte Growth Factor | 1 | 2001 | 268 | 0.040 |
Why?
|
DNA Replication | 1 | 2007 | 1433 | 0.040 |
Why?
|
Erythropoietin | 1 | 2004 | 716 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2003 | 760 | 0.040 |
Why?
|
MAP Kinase Signaling System | 2 | 2016 | 1490 | 0.040 |
Why?
|
Macrophages | 2 | 2013 | 5772 | 0.040 |
Why?
|
Porins | 1 | 1999 | 78 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4562 | 0.040 |
Why?
|
Neisseria meningitidis | 1 | 1999 | 111 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2263 | 0.040 |
Why?
|
bcl-X Protein | 2 | 2016 | 414 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5370 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2011 | 2176 | 0.040 |
Why?
|
Recurrence | 2 | 2023 | 8501 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 1145 | 0.040 |
Why?
|
Cross Reactions | 1 | 2000 | 824 | 0.040 |
Why?
|
Cricetinae | 1 | 2002 | 2411 | 0.040 |
Why?
|
Blotting, Western | 2 | 2016 | 5020 | 0.040 |
Why?
|
Clonal Deletion | 1 | 1998 | 75 | 0.040 |
Why?
|
Radiation Chimera | 1 | 1998 | 216 | 0.040 |
Why?
|
Peptide Fragments | 3 | 1999 | 5125 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2007 | 3715 | 0.040 |
Why?
|
Age Factors | 3 | 2011 | 18380 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 1999 | 334 | 0.040 |
Why?
|
Vimentin | 1 | 2019 | 258 | 0.040 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 67 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 1999 | 328 | 0.040 |
Why?
|
Ligands | 3 | 2011 | 3273 | 0.040 |
Why?
|
Oxides | 1 | 2019 | 402 | 0.040 |
Why?
|
Lymphocyte Transfusion | 1 | 1999 | 236 | 0.040 |
Why?
|
Proteinuria | 2 | 1997 | 607 | 0.040 |
Why?
|
Endothelins | 1 | 1997 | 127 | 0.040 |
Why?
|
Ferric Compounds | 1 | 2019 | 368 | 0.040 |
Why?
|
Podocytes | 1 | 2021 | 391 | 0.040 |
Why?
|
Mice, Transgenic | 5 | 2011 | 9550 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2007 | 1799 | 0.040 |
Why?
|
Genotype | 1 | 2012 | 13024 | 0.040 |
Why?
|
Islets of Langerhans Transplantation | 2 | 1999 | 746 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2004 | 1514 | 0.030 |
Why?
|
Myosins | 1 | 2019 | 408 | 0.030 |
Why?
|
Fluorenes | 1 | 2018 | 160 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12509 | 0.030 |
Why?
|
Immunodominant Epitopes | 1 | 1998 | 244 | 0.030 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 1997 | 92 | 0.030 |
Why?
|
Chemokine CCL5 | 1 | 1997 | 213 | 0.030 |
Why?
|
Abscess | 1 | 2000 | 606 | 0.030 |
Why?
|
Algorithms | 1 | 2017 | 14071 | 0.030 |
Why?
|
Postoperative Care | 1 | 2003 | 1470 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2015 | 22223 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 1999 | 605 | 0.030 |
Why?
|
Tissue Preservation | 1 | 2017 | 169 | 0.030 |
Why?
|
HT29 Cells | 1 | 2016 | 187 | 0.030 |
Why?
|
Microspheres | 1 | 2019 | 773 | 0.030 |
Why?
|
DNA Primers | 2 | 2017 | 2825 | 0.030 |
Why?
|
Thailand | 1 | 2017 | 287 | 0.030 |
Why?
|
Models, Biological | 2 | 2006 | 9443 | 0.030 |
Why?
|
Immunoglobulin G | 6 | 2011 | 4528 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 245 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 2423 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6069 | 0.030 |
Why?
|
Mutation | 3 | 2018 | 30198 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 399 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2016 | 197 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2007 | 1995 | 0.030 |
Why?
|
Immunization, Passive | 1 | 1998 | 616 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2020 | 839 | 0.030 |
Why?
|
Chemokines | 1 | 1999 | 956 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3850 | 0.030 |
Why?
|
Pain | 1 | 2010 | 5077 | 0.030 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.030 |
Why?
|
Brain Death | 1 | 1998 | 360 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1880 | 0.030 |
Why?
|
Growth Substances | 1 | 1997 | 758 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 1 | 2016 | 348 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3584 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1999 | 1628 | 0.030 |
Why?
|
Rabbits | 2 | 2011 | 4734 | 0.030 |
Why?
|
Autoimmune Diseases | 2 | 2011 | 2226 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1999 | 995 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2012 | 1162 | 0.030 |
Why?
|
Oligopeptides | 1 | 1999 | 1192 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1997 | 1132 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 295 | 0.030 |
Why?
|
Pancreatitis, Chronic | 1 | 2016 | 282 | 0.030 |
Why?
|
Cold Temperature | 1 | 1997 | 794 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 2 | 2007 | 355 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 1999 | 1476 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1997 | 746 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1410 | 0.030 |
Why?
|
Pravastatin | 1 | 2015 | 391 | 0.030 |
Why?
|
Hematopoiesis | 2 | 1999 | 2058 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10563 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 2013 | 323 | 0.030 |
Why?
|
Body Mass Index | 1 | 2011 | 13039 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 586 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 864 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 990 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2012 | 26318 | 0.030 |
Why?
|
Motion | 1 | 2016 | 781 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2822 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1998 | 975 | 0.030 |
Why?
|
Nephrectomy | 1 | 1997 | 927 | 0.030 |
Why?
|
Niacin | 1 | 2013 | 116 | 0.030 |
Why?
|
Yugoslavia | 1 | 2011 | 23 | 0.020 |
Why?
|
Neuroleptic Malignant Syndrome | 1 | 1992 | 74 | 0.020 |
Why?
|
Behavior Therapy | 1 | 2017 | 884 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3807 | 0.020 |
Why?
|
Pilot Projects | 2 | 2017 | 8733 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
Medicare | 2 | 2021 | 6823 | 0.020 |
Why?
|
Microscopy | 1 | 2016 | 901 | 0.020 |
Why?
|
Video Recording | 1 | 2016 | 969 | 0.020 |
Why?
|
Stem Cells | 1 | 2004 | 3540 | 0.020 |
Why?
|
Hepacivirus | 1 | 2018 | 1343 | 0.020 |
Why?
|
Cystoscopy | 1 | 2011 | 128 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5753 | 0.020 |
Why?
|
Iron | 1 | 2019 | 1816 | 0.020 |
Why?
|
Reoperation | 1 | 2021 | 4294 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 369 | 0.020 |
Why?
|
Cell Division | 3 | 2004 | 4475 | 0.020 |
Why?
|
Turkey | 1 | 2011 | 281 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1192 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 596 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 643 | 0.020 |
Why?
|
Base Sequence | 2 | 2017 | 12403 | 0.020 |
Why?
|
Immunoglobulin M | 3 | 1999 | 1528 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7838 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2007 | 5508 | 0.020 |
Why?
|
Up-Regulation | 2 | 2011 | 4137 | 0.020 |
Why?
|
Antibody Formation | 3 | 1999 | 1391 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2014 | 20124 | 0.020 |
Why?
|
Germany | 1 | 2011 | 882 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2631 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 891 | 0.020 |
Why?
|
Spleen | 3 | 1999 | 2296 | 0.020 |
Why?
|
Cell Polarity | 1 | 2011 | 636 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2936 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1701 | 0.020 |
Why?
|
Artifacts | 1 | 2016 | 1893 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6547 | 0.020 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2007 | 110 | 0.020 |
Why?
|
Coronary Disease | 1 | 2001 | 5912 | 0.020 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2007 | 152 | 0.020 |
Why?
|
Ofloxacin | 1 | 2007 | 66 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2011 | 1837 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9591 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5329 | 0.020 |
Why?
|
Immunotherapy | 1 | 2002 | 4752 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3620 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6309 | 0.020 |
Why?
|
Rural Population | 1 | 2017 | 2317 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2630 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3211 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2517 | 0.020 |
Why?
|
Survival Analysis | 2 | 2011 | 10070 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2216 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1157 | 0.010 |
Why?
|
Cytosine | 1 | 2006 | 213 | 0.010 |
Why?
|
Naphthyridines | 1 | 2007 | 182 | 0.010 |
Why?
|
Ciprofloxacin | 1 | 2007 | 314 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2485 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3432 | 0.010 |
Why?
|
Neurons | 1 | 2004 | 9525 | 0.010 |
Why?
|
Isoxazoles | 1 | 2006 | 234 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2016 | 4493 | 0.010 |
Why?
|
Child | 2 | 2023 | 80564 | 0.010 |
Why?
|
Medicaid | 1 | 2017 | 2833 | 0.010 |
Why?
|
Length of Stay | 2 | 2011 | 6485 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3910 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1624 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 637 | 0.010 |
Why?
|
Rats, Nude | 1 | 2003 | 105 | 0.010 |
Why?
|
Receptors, OX40 | 1 | 2003 | 46 | 0.010 |
Why?
|
Tumor Necrosis Factors | 1 | 2003 | 109 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16721 | 0.010 |
Why?
|
Quinolones | 1 | 2006 | 387 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36532 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 413 | 0.010 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2007 | 844 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 2003 | 315 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2011 | 2132 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2001 | 204 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2001 | 238 | 0.010 |
Why?
|
Exercise | 1 | 2017 | 5937 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2007 | 1375 | 0.010 |
Why?
|
Central Nervous System | 2 | 2000 | 1341 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 608 | 0.010 |
Why?
|
Carotid Artery Injuries | 1 | 2001 | 96 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2001 | 610 | 0.010 |
Why?
|
Anti-Glomerular Basement Membrane Disease | 1 | 2000 | 41 | 0.010 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2000 | 110 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2007 | 2412 | 0.010 |
Why?
|
Diet | 1 | 2017 | 8086 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8041 | 0.010 |
Why?
|
Myelin Proteins | 1 | 2000 | 212 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1999 | 128 | 0.010 |
Why?
|
Perforin | 1 | 1999 | 166 | 0.010 |
Why?
|
Rats, Inbred ACI | 1 | 1998 | 34 | 0.010 |
Why?
|
Cadaver | 1 | 2003 | 1359 | 0.010 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 1999 | 165 | 0.010 |
Why?
|
Basement Membrane | 1 | 2000 | 349 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15880 | 0.010 |
Why?
|
Virus Replication | 1 | 2007 | 2447 | 0.010 |
Why?
|
Drug Synergism | 1 | 2003 | 1749 | 0.010 |
Why?
|
Tunica Intima | 1 | 2001 | 455 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42500 | 0.010 |
Why?
|
Cell Separation | 1 | 2004 | 1718 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3401 | 0.010 |
Why?
|
Fasting | 1 | 2004 | 1606 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1999 | 914 | 0.010 |
Why?
|
Immunization Schedule | 1 | 1999 | 228 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1966 | 0.010 |
Why?
|
Thymectomy | 1 | 1999 | 200 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2000 | 13400 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 1999 | 438 | 0.010 |
Why?
|
Demyelinating Diseases | 1 | 2000 | 355 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13266 | 0.010 |
Why?
|
Fibrin | 1 | 2000 | 513 | 0.010 |
Why?
|
Heme Oxygenase-1 | 1 | 1999 | 364 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2002 | 1183 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14652 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6942 | 0.010 |
Why?
|
Neisseria gonorrhoeae | 1 | 1999 | 248 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11206 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1999 | 1770 | 0.010 |
Why?
|
Patient Selection | 1 | 2008 | 4255 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 287 | 0.010 |
Why?
|
Catheterization | 1 | 2001 | 1425 | 0.010 |
Why?
|
Injections | 1 | 1998 | 840 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 1999 | 1053 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10729 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14751 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 813 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 1999 | 1024 | 0.010 |
Why?
|
Fibrosis | 1 | 2001 | 2070 | 0.010 |
Why?
|
Mice, Nude | 1 | 1999 | 3618 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2000 | 1789 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1999 | 1118 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4850 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9373 | 0.010 |
Why?
|
Trifluoperazine | 1 | 1992 | 40 | 0.010 |
Why?
|
RNA | 1 | 2001 | 2717 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7202 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1992 | 682 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8102 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2001 | 3096 | 0.010 |
Why?
|
Cell Lineage | 1 | 1998 | 2573 | 0.000 |
Why?
|
Interleukin-2 | 1 | 1995 | 1896 | 0.000 |
Why?
|
Ischemia | 1 | 1997 | 1909 | 0.000 |
Why?
|
Piperidines | 1 | 1997 | 1664 | 0.000 |
Why?
|
Escherichia coli Infections | 1 | 1992 | 519 | 0.000 |
Why?
|
Myocardium | 1 | 2001 | 4760 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 17594 | 0.000 |
Why?
|
Vaccination | 1 | 1999 | 3426 | 0.000 |
Why?
|
Urinary Tract Infections | 1 | 1992 | 805 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1999 | 7599 | 0.000 |
Why?
|
Blood Glucose | 1 | 1999 | 6424 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1992 | 1275 | 0.000 |
Why?
|
Sex Factors | 1 | 1997 | 10603 | 0.000 |
Why?
|
Depressive Disorder | 1 | 1992 | 3714 | 0.000 |
Why?
|
Brain | 1 | 2004 | 27171 | 0.000 |
Why?
|